Middle East and Africa Infection Control Market Size Growth Analysis;
The Middle East and Africa (MEA) infection control market is projected to reach USD 1436.9 million by 2025 from USD 974.1 million in 2018, at a CAGR of 5.80% during the forecast period.
According to Research Cosmos Analysis, Global Infection Control Market projected to reach USD 30,002.1 Million by 2025, growing with a CAGR of 6.77%.
The MEA market is predominantly driven by the growing number of surgical procedures that require high-intensity infection prevention. The great preference is presumed to be a consequence of positive clinical results associated with the usage of infection control.
Growth Opportunities, Challenges and Restraints:
The growing number of government initiatives to ensure high degree infection prevention is presumed to be an important driver of the market. The government institutions are frequently involved in issuing guidelines in order to raise awareness pertaining to effective blocking measures globally, which is anticipated to offer to the market growth throughout the forecast period.
The circumstances expected to drive the market in this region include growing focus on the outsourcing of sterilization processes among pharmaceutical companies, hospitals, and medical device manufacturers; growing prevalence of hospital-acquired infections; increase in the number of surgical methods; and mounting focus on food sterilization. Although, the harmful effects of ethylene oxide may restrict the growth of the infection control market to some extent.
As per the data published in the National Nosocomial Infection Surveillance (NNIS) system, most hospital-acquired UTIs are connected with catheterization and CA-bacteriuria is the most frequently occurring method, considering for up to 40% of HAIs each year. These circumstances are expected to widen the future growth prospects of the market.
Under consumables, personal protective equipment held a substantial share in 2016. Various healthcare organizations are advocating and promoting awareness pertaining to the benefits of personal protective equipment, which is expected to be responsible for the significant share. For example, the WHO, released guidelines in 2014 covering recommendations and strategies for the usage of all main infection control products, including personal protective equipment.
The growth of the MEA market can be attributed to the growing demand of disinfection and sterilization commodities and services among pharmaceutical corporations, hospitals, and medical device manufacturers; growing prevalence of hospital-acquired infections; increase in the number of surgical procedures and increasing focus on food sterilization and disinfection. Also, circumstances such as the growth in the emerging markets, medical devices market, and the rising importance of single-use medical nonwovens and devices are additionally providing growth opportunities for players in the MEA infection control market.
In the type segment, services are anticipated to grow at a lucrative rate throughout the projected period. This fastest growth is attributed to the great inclination of market players to reduce overall healthcare expenditure along with the utilization of benefits involved. It essentially includes cost advantages, improved efficiency of services, enhanced productivity, and a significantly greater focus on the core areas of development, which are extremely critical to a company’s overall profit and growth.
Geographical Insights of Middle East and Africa Infection Control Market
Geographically the MEA infection control market is divided into Saudi Arabia, UAE, Egypt, Nigeria, South Africa, and the Rest of MEA. The competition is marked by the extensive implementation of collaborative plans by major companies such as Advanced Sterilization Products, STRAUS Corporation, Cantel Medical Corporation, which accounts for their commanding market share. These players are very focused on adopting competitive strategies such as mergers & acquisitions, development initiatives, new product, and geographical expansion.
For instance, in March 2017, 3M and Kimberly-Clark Health Care signed an alliance to co-develop and produce surgical and infection prevention solutions utilizing their particular expertise. Similarly, in July 2016, 3M launched four-hour rapid readout biological pointer for vaporized hydrogen peroxide sterilization, intended to give results in four hours and monitored steam sterilization loads. The product was started to expand the company’s product portfolio.
Few of the leading companies dominating the Market profiled in the report are
- 3M and Advanced Sterilization Products
- Cantel Medical
- Sotera Health
- MMM Group
- Belimed AG
- Reckitt Benckiser
- Halyard Health
- Metrix Research
- Pal International
This research report includes following segmentation for the Middle East and Africa Infection Control Market size and forecast
Middle East and Africa Infection Control Market - By Products and Services
- Disinfection Products
- Sterilization Products & Services
Middle East and Africa Infection Control Market - By End User
- Hospitals & Clinics
- Life Sciences Industry
- Medical Devices Companies
- Food Industry
- Pharmaceutical Companies
Middle East and Africa Infection Control Market – By Region